Ami06 0007 01
Chemical structure of amikacin sulfate showing its molecular arrangement and sulfate group association.*
Amikacin Sulfate Injection, Solution
Product Images NDC 25021-173
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amikacin Sulfate (NDC 25021-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ami06 0007 02
A text panel showing dosing information related to maintenance dose and creatinine clearance rate (CC) for calculating loading doses. Terms like observed CC, normal CC, and dosing intervals are visible, with instructional content on dosage calculations.*
Ami06 0007 03
Amikacin Sulfate Injection, USP 500 mg per 2 mL (250 mg per mL) vial label from Sagent Pharmaceuticals. The label indicates the product is for intramuscular or intravenous use, single-dose vial, with storage instructions at 20°C to 25°C (68°F to 77°F). Manufactured in Spain, it includes a barcode and space for lot and expiration dates.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
